BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34600331)

  • 41. Facile synthesis and
    Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K
    Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and studies of thiazolidinedione-isatin hybrids as α-glucosidase inhibitors for management of diabetes.
    Kaur R; Kumar R; Dogra N; Kumar A; Yadav AK; Kumar M
    Future Med Chem; 2021 Mar; 13(5):457-485. PubMed ID: 33506699
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives.
    Nawaz M; Taha M; Qureshi F; Ullah N; Selvaraj M; Shahzad S; Chigurupati S; Abubshait SA; Ahmad T; Chinnam S; Hisaindee S
    J Biomol Struct Dyn; 2022; 40(21):10730-10740. PubMed ID: 34463216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
    Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemical profiling of secondary metabolites from Himatanthus drasticus (Mart.) Plumel latex with inhibitory action against the enzymes α-amylase and α-glucosidase: In vitro and in silico assays.
    Morais FS; Canuto KM; Ribeiro PRV; Silva AB; Pessoa ODL; Freitas CDT; Alencar NMN; Oliveira AC; Ramos MV
    J Ethnopharmacol; 2020 May; 253():112644. PubMed ID: 32058007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
    Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
    Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from
    Feunaing RT; Tamfu AN; Gbaweng AJY; Mekontso Magnibou L; Ntchapda F; Henoumont C; Laurent S; Talla E; Dinica RM
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
    Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
    BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents.
    Acar Çevik U; Celik I; Paşayeva L; Fatullayev H; Bostancı HE; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200663. PubMed ID: 36760015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
    Trinh BTD; Staerk D; Jäger AK
    J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles.
    Shah S; Arshia ; Javaid K; Zafar H; Mohammed Khan K; Khalil R; Ul-Haq Z; Perveen S; Iqbal Choudhary M
    Bioorg Chem; 2018 Aug; 78():269-279. PubMed ID: 29614438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation.
    Ragab A; Salem MA; Ammar YA; Aboulthana WM; Helal MH; Abusaif MS
    Drug Dev Res; 2024 Jun; 85(4):e22216. PubMed ID: 38831547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New triazinoindole bearing thiazole/oxazole analogues: Synthesis, α-amylase inhibitory potential and molecular docking study.
    Rahim F; Tariq S; Taha M; Ullah H; Zaman K; Uddin I; Wadood A; Khan AA; Rehman AU; Uddin N; Zafar S; Shah SAA
    Bioorg Chem; 2019 Nov; 92():103284. PubMed ID: 31546207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phlorotannin constituent of Ecklonia cava alleviates postprandial hyperglycemia in diabetic mice.
    Lee HA; Lee JH; Han JS
    Pharm Biol; 2017 Dec; 55(1):1149-1154. PubMed ID: 28219252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. α-Glucosidase and α-amylase inhibitors from Myrcia spp.: a stronger alternative to acarbose?
    Figueiredo-González M; Grosso C; Valentão P; Andrade PB
    J Pharm Biomed Anal; 2016 Jan; 118():322-327. PubMed ID: 26590699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2-Aryl benzimidazoles: Synthesis, In vitro α-amylase inhibitory activity, and molecular docking study.
    Adegboye AA; Khan KM; Salar U; Aboaba SA; Kanwal ; Chigurupati S; Fatima I; Taha M; Wadood A; Mohammad JI; Khan H; Perveen S
    Eur J Med Chem; 2018 Apr; 150():248-260. PubMed ID: 29533872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
    Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
    Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
    Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
    Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.